title: Total parenteral nutrition-related gastroenterological complications.
abstract: Total parenteral nutrition is a life saving therapy for patients with chronic gastrointestinal failure, being an effective method for supplying energy and nutrients when oral or enteral feeding is impossible or contraindicated. Clinical epidemiological data indicate that total parenteral nutrition may be associated with a variety of problems. Herein we reviewed data on the gastroenterological tract regarding: (i) total parenteral nutrition-related hepatobiliary complications; and (ii) total parenteral nutrition-related intestinal complications. In the first group, complications may vary from mildly elevated liver enzyme values to steatosis, steatohepatitis, cholestasis, fibrosis and cirrhosis. In particular, total parenteral nutrition is considered to be an absolute risk factor for the development of biliary sludge and gallstones and is often associated with hepatic steatosis and intrahepatic cholestasis. In general, the incidence of total parenteral nutrition-related hepatobiliary complications has been reported to be very high, ranging from 20 to 75% in adults. All these hepatobiliary complications are more likely to occur after long-term total parenteral nutrition, but they seem to be less frequent, and/or less severe in patients who are also receiving oral feeding. In addition, end-stage liver disease has been described in approximately 15-20% of patients receiving prolonged total parenteral nutrition. Total parenteral nutrition-related intestinal complications have not yet been adequately defined and described. Epidemiological studies intended to define the incidence of these complications, are still ongoing. Recent papers confirm that in both animals and humans, total parenteral nutrition-related intestinal complications are induced by the lack of enteral stimulation and are characterised by changes in the structure and function of the gut. Preventive suggestions and therapies for both these gastroenterological complications are reviewed and reported in the present review.
authors.affiliation: Section of Gastroenterology, Department of Emergency and Organ Transplantation, University of Bari, Piazza G. Cesare 11, 70124 Bari, Italy. william@gastro.uniba.it
authors.forename: F W
authors.initials: FW
authors.lastname: Guglielmi
authors.forename: D
authors.initials: D
authors.lastname: Boggio-Bertinet
authors.forename: A
authors.initials: A
authors.lastname: Federico
authors.forename: G B
authors.initials: GB
authors.lastname: Forte
authors.forename: A
authors.initials: A
authors.lastname: Guglielmi
authors.forename: C
authors.initials: C
authors.lastname: Loguercio
authors.forename: S
authors.initials: S
authors.lastname: Mazzuoli
authors.forename: M
authors.initials: M
authors.lastname: Merli
authors.forename: A
authors.initials: A
authors.lastname: Palmo
authors.forename: C
authors.initials: C
authors.lastname: Panella
authors.forename: L
authors.initials: L
authors.lastname: Pironi
authors.forename: A
authors.initials: A
authors.lastname: Francavilla
mesh_terms: D000818:Animals; D001660:Biliary Tract Diseases / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007422:Intestines / Q000276:immunology; D008107:Liver Diseases / Q000209:etiology* / Q000628:therapy; D010289:Parenteral Nutrition, Total / Q000009:adverse effects*; D012307:Risk Factors